Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,185.00
-130.00 (-5.62%)
At close: Jun 19, 2026

Theragen Etex Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
272,927271,590249,625216,470190,769166,567
Other Revenue
----0-0-
272,927271,590249,625216,470190,769166,567
Revenue Growth (YoY)
5.78%8.80%15.32%13.47%14.53%16.46%
Cost of Revenue
131,715130,576123,644116,344113,363105,392
Gross Profit
141,212141,013125,981100,12677,40661,175
Selling, General & Admin
125,880123,116106,39680,55559,73152,810
Research & Development
4,4044,3594,1284,0445,0386,515
Amortization of Goodwill & Intangibles
36.240.7484.588.5478.04216.99
Other Operating Expenses
899.43933.52764.24276.75405.44261.95
Operating Expenses
133,555130,800114,33588,65365,55368,602
Operating Income
7,65810,21311,64611,47311,853-7,427
Interest Expense
-2,263-2,332-2,676-2,418-1,343-1,691
Interest & Investment Income
1,053979.03776.69799.02340.94327.69
Earnings From Equity Investments
-148.76-5,695---
Currency Exchange Gain (Loss)
254.7-26.15126.412.63.7997.9
Other Non Operating Income (Expenses)
-721.51-1,547-2,486396.13-369.03-2,136
EBT Excluding Unusual Items
5,8327,28713,08210,25310,486-10,829
Gain (Loss) on Sale of Investments
10,27310,276-56,03622,164-60.8512.93
Gain (Loss) on Sale of Assets
1.6513.48150.68-46.624,231-219.2
Asset Writedown
---26.22-62.69-800.7-1,477
Other Unusual Items
--37.43-329.08439.82--163.19
Pretax Income
16,10717,539-43,15932,74713,855-12,676
Income Tax Expense
5,3075,793-3,0183,0691,428-1,291
Earnings From Continuing Operations
10,80011,746-40,14129,67912,428-11,385
Earnings From Discontinued Operations
--860.46-1,287-1,477-
Net Income to Company
10,80011,746-39,28128,39210,951-11,385
Minority Interest in Earnings
-1,070-1,145-1,704-2,180-1,389-469.31
Net Income
9,73010,600-40,98526,2119,561-11,854
Net Income to Common
9,73010,600-40,98526,2119,561-11,854
Net Income Growth
---174.14%--
Shares Outstanding (Basic)
373632323232
Shares Outstanding (Diluted)
383732323232
Shares Change (YoY)
17.02%14.95%-0.03%-0.04%1.88%
EPS (Basic)
265.15296.43-1281.00818.97298.74-370.52
EPS (Diluted)
259.72290.00-1281.00818.97297.86-371.00
EPS Growth
---174.95%--
Free Cash Flow
8,0178,396-9,6047,3285,4011,257
Free Cash Flow Per Share
212.57228.28-300.17228.96168.7439.30
Gross Margin
51.74%51.92%50.47%46.25%40.58%36.73%
Operating Margin
2.81%3.76%4.67%5.30%6.21%-4.46%
Profit Margin
3.56%3.90%-16.42%12.11%5.01%-7.12%
Free Cash Flow Margin
2.94%3.09%-3.85%3.38%2.83%0.76%
EBITDA
14,17216,68917,74317,31716,945-2,387
EBITDA Margin
5.19%6.14%7.11%8.00%8.88%-1.43%
D&A For EBITDA
6,5156,4766,0965,8445,0925,041
EBIT
7,65810,21311,64611,47311,853-7,427
EBIT Margin
2.81%3.76%4.67%5.30%6.21%-4.46%
Effective Tax Rate
32.95%33.03%-9.37%10.30%-
Advertising Expenses
-280.76246.75430.63430.06194.09